67
Participants
Start Date
August 2, 2017
Primary Completion Date
December 18, 2019
Study Completion Date
September 11, 2026
Atezolizumab
Given IV
Biospecimen Collection
Undergo collection of blood samples
Carboplatin
Given IV
Lumpectomy
Undergo lumpectomy
Mastectomy
Undergo mastectomy
Paclitaxel
Given IV
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Duke University Medical Center, Durham
Ohio State University Comprehensive Cancer Center, Columbus
Washington University School of Medicine, St Louis
Siteman Cancer Center-South County, St Louis
Siteman Cancer Center at Christian Hospital, St Louis
Siteman Cancer Center at West County Hospital, Creve Coeur
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
Mayo Clinic Hospital in Arizona, Phoenix
Mayo Clinic in Arizona, Scottsdale
University of California Davis Comprehensive Cancer Center, Sacramento
Mayo Clinic in Florida, Jacksonville
National Cancer Institute (NCI)
NIH